For example, venotoclax-resistant AML can in some instances arise from a monocytic LSC (m-LSC) as opposed to a more primitive LSC (p-LSC) with a distinct bulk immunophenotype (CD4+CD34–CD11b–CD14–CD36–)34,35. The gene discussed is CD4; the disease is acute myeloid leukemia.